Biodexa Pharmaceuticals PLC (BDRX)

5.70 +0.02 (+0.35%) USD  |  NASDAQ  |  Nov 05, 11:39
More

Biodexa Pharmaceuticals EPS Estimates for Current Fiscal Year

EPS Estimates for Current Fiscal Year Chart

View EPS Estimates for Current Fiscal Year for BDRX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical EPS Estimates for Current Fiscal Year Data

View and export this data back to 2023. Upgrade now.
Date Value
June 04, 2024 --
February 08, 2024 --
Date Value
December 31, 2023 --

Earnings Per Share Estimates Definition

This is the earnings consensus estimate for a given period of time, according to analysts polled by Standard & Poor's.

Read full definition.

EPS Estimates for Current Fiscal Year Range, Past 5 Years

Upgrade
Minimum
Dec 31 2023
Upgrade
Maximum
Jun 04 2024
Upgrade
Average
Upgrade
Median
Feb 08 2024

EPS Estimates for Current Fiscal Year Benchmarks

Adaptimmune Therapeutics PLC Upgrade
Verona Pharma PLC Upgrade
NuCana PLC Upgrade
Autolus Therapeutics PLC Upgrade
TC BioPharm (Holdings) PLC --

EPS Estimates for Current Fiscal Year Related Metrics

Revenue Estimates for Current Fiscal Year Upgrade
Revenue Estimates for Next Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade